In individuals with meningococcal disease, translocation of Neisseria meningitidis from the bloodstream across the bloodbrain barrier is the critical pathogenic step leading to meningitis. Despite recent discoveries relating to mechanisms of blood-brain barrier penetration [1] , knowledge about the relative contribution of microbial and host factors in meningeal infection during meningococcal disease is superficial. Data relating to other Gramnegative pathogens (eg, Haemophilus influenzae) [2] suggest highlevel or sustained bacteremia is required for meningeal invasion.
Culture-confirmed meningitis caused by infection with serogroup C N. meningitidis, typed by multilocus sequence typing as clonal-complex 11, has been associated with poor outcomes [3] . We demonstrated elsewhere that high plasma genomic bacterial load in meningococcal disease increases the likelihood of death, permanent disease sequelae, and prolonged hospitalization. Peripheral bacterial load was significantly higher in patients with serogroup C N. meningitidis infection than in those infected with non-C serogroups [4] . In this work, we investigate factors affecting N. meningitidis DNA detection and bacterial load quantification within the cerebrospinal fluid (CSF) to determine their relative significance in development of meningococcal meningitis and neurologic sequelae.
METHODS
United Kingdom medical practitioners are legally obliged to report cases of suspected meningitis to the authorities. As part of this requirement, samples from the diagnostic workup are submitted to the Meningococcal Reference Unit for England and Wales (MRU), including CSF samples if clinically indicated. Multiplex polymerase chain reaction (PCR)-based assays for detecting DNA sequences, including the N. meningitidis-specific capsular transfer gene (ctrA), are performed on CSF and ethylenediaminetetraacetic acid-treated blood samples. Quantified genomic bacterial load by this method is accurate between log 10 3 and log 10 9 copies/mL [5] .
Epidemiologic, clinical, and microbiologic data from July 1997 to August 2004 were analyzed with host single-nucleotide polymorphisms (SNPs) at IL-1B (2511), IL-1RN (12018) and TNF (2308) positions (rs16944, rs315952, and rs1800629, respectively), as described elsewhere [6, 7] . All data were anonymized after collection. Ethical approval was granted by the Public Health Service (now the Health Protection Agency, Colindale, London) and South Sheffield Ethics Committee (Sheffield, United Kingdom).
Statistical analysis was performed using SPSS software (version 19, IBM). After preliminary univariate analysis (MannWhitney U test for continuous and v 2 test for categorical data), multivariate and linear regression modeling was performed, with P , .05 considered significant. Before regression modeling, bacterial load data were log 10 transformed because of nonnormal distribution and are presented as n log 10 copies DNA per milliliter of blood or CSF.
RESULTS
A total of 384 patients with subsequently confirmed meningococcal disease (defined as detection of N. meningitidis from any sterile site by culture or PCR) had CSF samples submitted to the MRU; 300 samples (78%) were submitted with a contemporary, paired ethylenediaminetetraacetic acid-treated blood sample. (Figure 1 ). In patients with serogroup B infection, there was no correlation between peripheral and CSF bacterial load. Even low levels of bacteremia in patients with serogroup B infection were often associated with extremely high quantities of bacteria within the CSF (Figure 1 ).
Effect of Cerebrospinal Fluid Genomic Bacterial Load on Clinical Outcome
Patients who subsequently developed persistent auditory deficit had significantly higher CSF bacterial loads than those without such deficit, irrespective of the infecting serogroup (odds ratio,1.956; 95% CI, 1.149-3.328; P 5 .013, logistic regression). As was evident in the larger cohort analyzed elsewhere, of which this group is a part [4] , a significant protective effect against auditory sequelae was afforded by carriage of the rare allele at IL1RN (12018) (odds ratio, 0.52; 95% CI, .28-.97; P 5 .038, logistic regression).
DISCUSSION
We found that PCR detection of N. meningitidis within the CSF of patients with confirmed meningococcal infection was more likely in serogroup B infection, in older patients, and in patients receiving antibiotics before hospitalization. Patients with overt signs of meningeal inflammation are more likely to receive antibiotics before hospitalization and also to undergo lumbar puncture, which probably explains the statistical relationship with antibiotic therapy. The sensitivity of PCR N. meningitidis detection in CSF is 88.9%, compared with 90.4% in plasma specimens [5] . The rate of N. meningitidis detection in CSF samples from this cohort of patients with confirmed meningococcal infection may have been lower than that expected based on previous observations from other national cohorts; for example, up to 63% of bacteraemic patients had associated detection of N. meningitidis by PCR within the CSF in a French surveillance study [8] . There have been recent reports of false-negative PCR findings attributed to an observed sequence variation in a clonal variant belonging to ST 269, grouped as B or C N. meningitidis [9] , but such results were not common in UK monitoring during the current study period. Subsequently, an additional reverse primer has been included in the assay, as described by Corless et al [5] .
Bacterial loads within the CSF correlated positively with peripheral bacterial loads in patients with non-serogroup B infection, consistent with data from non-N. meningitidis experimental models in which prolonged or intense bacteremia encourages meningeal penetration [2] . In contrast, patients presenting with serogroup B infection demonstrated a different profile of bacterial distribution: most noticeably extremely high CSF bacterial loads despite modest levels of bacteremia producing much higher CSF-plasma bacterial load ratios overall (data not shown). This could be due to preferential uptake, involving, for example, type IV pilus attachment, more aggressive paracellular penetration of the endothelial lining active replication within the CSF, or other undetermined mechanisms [1] . During the period when these data were collected, there was a national expansion of isolates of serogroup B expressing clonal complex cc269 in the United Kingdom [10] , but whether this clone underlies the serogroup-specific dissociation observed in our study cannot be determined with the data currently available. This greater bacterial load of serogroup B strains would create a greater lipopolysaccharide burden and a proinflammatory host response, possibly leading to more florid meningeal symptoms and hence earlier presentation to medical services and institution of antibiotic treatment for a clinical diagnosis of meningitis.
The other association with CSF bacterial load in our final model was the host TNF2 (2308A) promoter polymorphism. This variation has been associated with elevated TNF-a production and susceptibility and severity of meningococcal disease [6, 11] . We have demonstrated that patients with this allotype have higher bacterial loads within the CSF, particularly in the presence of serogroup B infection. We were unable to demonstrate a direct effect of polymorphisms within the IL-1/IL1-RN complex on CSF bacterial load, however, carriage of IL1-RN (12018) (conveying a proinflammatory phenotype) was associated with protection against subsequent auditory deficit. We have demonstrated elsewhere that patients carrying this polymorphism have an increased risk of death [4, 7] , altogether, it seems possible that a proinflammatory state may protect against hearing loss, via reduction in the CSF bacterial load, but not against the massive cytokine dysregulation seen in fulminant meningococcal sepsis.
This study reports the largest data set of patients with confirmed meningococcal disease and individual clinical, microbiologic, and CSF bacterial genomic loads to date.
Processing of samples at a central reference laboratory excluded interlaboratory variation of results. Transport of clinical specimens might cause some degradation of genetic material during shipment, but the maximum distances covered are not great. We cannot exclude contamination of CSF results by blood cells and therefore, potentially, bacteria detectable at low levels by this sensitive technique.
In summary, our most novel finding is that infection with serogroup B-expressing N. meningitidis is associated with a high bacterial load within the CSF, despite apparently low levels in the peripheral circulation, and this is additionally influenced by host genotype including TNF2 (2308A). This may explain, in part, the frequency with which patients with serogroup B infection present with meningitis [12] .
